Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RIPK1 | Q13546 | 20/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17312639 | 1.00 | RIPK1 (1.00) | RIPK1 | |
| SCHEMBL15964718 | 1.00 | RIPK1 (1.00) | RIPK1 | |
| SCHEMBL17312377 | 0.94 | RIPK1 (0.88) | RIPK1 | |
| SCHEMBL17312375 | 0.94 | RIPK1 (0.88) | RIPK1 | |
| SCHEMBL15957034 | 0.90 | RIPK1 (0.82) | RIPK1 | |
| SCHEMBL15957148 | 0.90 | RIPK1 (0.82) | RIPK1 | |
| SCHEMBL17312532 | 0.90 | RIPK1 (0.82) | RIPK1 | |
| SCHEMBL15957150 | 0.90 | RIPK1 (0.82) | RIPK1 | |
| SCHEMBL15957031 | 0.90 | RIPK1 (0.82) | RIPK1 | |
| SCHEMBL17312533 | 0.90 | RIPK1 (0.82) | RIPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3612223-B1 | TREATING MALE SENESCENCE | NAT INSTITUTE OF BIOLOGICAL SCIENCES BEIJING (CN) | 2024-07-31 | — | — | EP | claimed |
| EP-4665334-A1 | TRIPLE KINASE INHIBITION FOR THE TREATMENT OF TYPE I INTERFERON RESPONSE ASSOCIATED DISORDERS | Universität zu Köln (DE) | 2025-12-24 | — | — | EP | disclosed |
| WO-2024170776-A1 | TRIPLE KINASE INHIBITION FOR THE TREATMENT OF TYPE I INTERFERON RESPONSE ASSOCIATED DISORDERS | UNIVERSITÄT ZU KÖLN (DE) | 2024-08-22 | — | — | WO | disclosed |
| CN-117320754-A | Prostatitis treatment | 北京生命科学研究所 | 2023-12-29 | — | — | CN | disclosed |
| EP-4017535-A1 | PROSTATITIS TREATMENT | National Institute Of Biological Sciences, Beijing (CN) | 2022-06-29 | — | — | EP | disclosed |